ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #5,620Hybrid

Pediatric Blood & Cancer

Acronym:pbc
•
Abbreviation (ISO):PEDIATR BLOOD CANCER
•
Identifier (ISSN):1545-5009(Print)/1545-5017(Online)
•
Publisher:Wiley-Liss Inc.
Clarivate IF (2026)
2.4↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pediatric Blood & Cancer

WoS Q2
12452.6520182.4920192.3520203.1720213.8420223.220232.420242.320252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q1
0.916
#5,620

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
138

138 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate12.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
446articles/year
36.12% Gold OA•90.95% Original Research

Aims & Scope

Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.

Topics Covered (Recognized by AI)
Medicine99.9%Biology86.4%Internal medicine85.8%Genetics74.5%Pathology62.7%Surgery50.6%Immunology36.4%Chemistry36.4%Biochemistry30.7%Pediatrics30.1%Cancer30%Psychology30%Oncology27.3%Radiology24%Chemotherapy23%Psychiatry22.8%Disease22.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q2
Rank51/103
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q3
Rank214/333
IndexSCIE
JCRSCIE2026

PEDIATRICS

Q2
Rank50/190
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q2
Rank34/103
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank157/333
IndexSCIE
JCISCIE2026

PEDIATRICS

Q3
Rank96/190
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.4
Articles / Year671
Total Citations108
2025
IF2.3
Articles / Year751
Total Citations1,076
2024
IF2.4
Articles / Year688
Total Citations2,002
2023
IF3.2
Articles / Year680
Total Citations3,737
2022
IF3.838
Articles / Year651
Total Citations4,813

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,620Scopus Q1SCImago Profile
Scopus Coverage:2004-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
0.916

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
1.70

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,313 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,503
3-Year Documents1,935
Citable Documents1,249

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate57.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Pediatrics, Perinatology and Child HealthQ1
HematologyQ2
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 12.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pediatric Blood & Cancer (acronym: pbc, abbr: PEDIATR BLOOD CANCER, ISSN: 1545-5009) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Liss Inc. in United States since 2004. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.916 (Q1), an H-index of 138.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 446 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,313 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Liss Inc.
Publication Language
English
Frequency
Monthly
Founding Year
2004
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f1f8c3fc-c760-4fdb-93f0-9b67b38157eb
Database Updated: 2026-10-01